Sex: M
Vaccine: COVID19
Symptoms: Influenza
Clinical narrative: Was in the hospital a few days for "unrelated reasons" to the flu/Coughing, and the coughing will likely last 6 months/Cold; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA (Was in the hospital a few days for "unrelated reasons" to the flu/Coughing, and the coughing will likely last 6 months/Cold) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Was in the hospital a few days for "unrelated reasons" to the flu/Coughing, and the coughing will likely last 6 months/Cold) (seriousness criterion hospitalization). At the time of the report, INFLUENZA (Was in the hospital a few days for "unrelated reasons" to the flu/Coughing, and the coughing will likely last 6 months/Cold) outcome was unknown.            Concomitant product use was not provided by the reporter.  The patient received two Moderna primary series doses and two Moderna booster doses.The patient stated his last booster dose was 4 or 5 months ago.  The patient was in the hospital a few days for unrelated reasons to the flu. Patient reported that during his hospital stay, he came down with the flu and reported he then had a cold. Patient stated that he was coughing, and the coughing will likely last 6 months.   Treatment information was not provided.  Company comment: This spontaneous case concerns an adult male patient with Concurrent medical conditions of Immunocompromised who experienced the unexpected serious (hospitalization) event of Influenza which occurred unspecified days after receiving the fourth dose of mRNA-1273 vaccine in covid-19 vaccination series. Latency cannot be assessed since vaccination date was not disclosed. The Clinical course, Concomitant medication, treatment details were not provided, and the event outcome was unknown.  Patient's Concurrent medical conditions of Immunocompromised remains a confounder. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Events seriousness was assessed as per medical judgement and available information.   This case was linked to MOD-2022-607773 (Patient Link).   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns an adult male patient with Concurrent medical conditions of Immunocompromised who experienced the unexpected serious (hospitalization) event of Influenza which occurred unspecified days after receiving the fourth dose of mRNA-1273 vaccine in covid-19 vaccination series. Latency cannot be assessed since vaccination date was not disclosed. The Clinical course, Concomitant medication, treatment details were not provided, and the event outcome was unknown.  Patient's Concurrent medical conditions of Immunocompromised remains a confounder. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Events seriousness was assessed as per medical judgement and available information.